HRT Financial’s 20/20 Biolabs AIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6K Sell
14,869
-74,404
-83% -$38.4K ﹤0.01% 4587
2026
Q2
$49K Buy
+89,273
New +$112K ﹤0.01% 3783

Other funds holding AIDX

HRT Financial's AIDX Position: Q3 2026 in Review

HRT Financial reduced its 20/20 Biolabs (AIDX) stake by 83% in Q3 2026, selling an estimated $38.4K and leaving 14,869 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #4587.

HRT Financial first reported a position in AIDX in Q2 2026 and has held it in 2 quarters since. The position peaked at $49K in Q2 2026. 16 funds tracked by Wall St. Rank hold AIDX as of Q3 2026.

  • HRT Financial held 14,869 shares of 20/20 Biolabs worth $6K as of Q3 2026.
  • HRT Financial sold 74,404 20/20 Biolabs shares in Q3 2026, an estimated $38.4K.
  • 20/20 Biolabs made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4587 holding.
  • HRT Financial first reported a position in 20/20 Biolabs in Q2 2026 and has held it in 2 quarters since.
  • HRT Financial's 20/20 Biolabs position peaked at $49K in Q2 2026.
  • 16 funds tracked by Wall St. Rank held 20/20 Biolabs as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.